Cardiovascular disease management |
||
Thursday, 11 April 2002 |
||
Organizers |
L. Badimon (Barcelona, Spain) | |
Sponsor |
Unrestricted Educational Grant fromSchering-Plough SA | |
Beyond statins for the control of hypercholesterolemia and cardiovascular disease |
||
Session I |
Abstract no |
|
Chair | L. Badimon (Barcelona, Spain) | |
9.45 – 10.15 |
Regulation of cholesterol absorption : clinical implications Klaus von Bergmann (Germany) |
|
10.15 – 10.45 |
Gene expression profiles in vascular wall (by lipoproteins) Lina Badimon (Spain) |
|
10.45 – 11.15 | coffee break | |
11.15 – 11.45 | Vascular protection and statinsAlberico L. Catapano (Italy) | |
11.45 – 12.00 |
Low density lipoprotein receptor-related protein is up-regulated by aggregated LDL in human vascular smooth muscle cells and by hypercholesterolemia in the arterial wall V. Llorente-Cortés, M. Otero-Viñas, S. Sánchez, C. Rodriguez, and L. Badimon (Barcelona, Spain) |
128
|
12.00 – 12.15 | MCP-1 gene upregulation induced by hypercholesterolemia is reduced by statin treatment in monocytes G. Vilahur, N. Ruíz, X. Duran, S. Sánchez, L. Casaní, and L. Badimon (Barcelona, Spain) |
129
|
12.15 – 12.30 |
Statins reduce inflammatory changes in endothelial cells in heterozygous familial hypercholesterolemia patients R. Alonso, L. Badimón , P. Catalina, P. Mata, on behalf of the Spanish Foundation for Familial Hypercholesterolemia. (Barcelona, Spain) |
130
|
12.30 | end of session I | |
12.30 – 14.00 | lunch and poster viewing | |
Session II |
Thursday, 11 April 2002 | |
Abstract no
|
||
15.00 – 15.15 |
C-reactive protein is affected by modifiable risk factors in heterozygous familial hypercholesterolemia patients R. Alonso, L. Badimón, P. Catalina, P. Mata on behalf of the Spanish Foundation for Familial Hypercholesterolemia (Barcelona, Spain) |
131
|
15.15 – 15.45 |
Imaging of plaques: impact on prevention Juan J. Badimon (USA) |
|
15.45 – 16.15 |
New drugs for reduction of cholesterol absorption: added benefits Lorenzo Melani (USA) |
|
16.15 – 16.45 |
New options to reduce cholesterol in hFH : combined therapy Francisco Pérez Jiménez (Spain) |
|
16.45 – 17.00 |
Post-cardiopulmonary bypass (CPB) euthyroid sick syndrome (ESS) is not correlated with bypass temperature but well with interleukine-6 levels P.M. Honoré, L.M. Jacquet, and M. Goenen (Brussels, Belgium) |
132
|
17.00 – 17.15 | Stimulation of collagen production by TGF-b1 during differentiation of cardiac fibroblasts to myofibroblastsV. Petrov, R. Fagard and P. Lijnen (Leuven, Belgium) |
133
|
17.00 | end of workshop 13 |